EarningsQ3 2026 Earnings Report

Resmed (RMD) Q3 2026 Earnings Report

2 Followers

MX:RMD Q3 2026 EPS Results

Actual EPS$51.69

Consensus EPS$50.52

Beat/MissBeat by +$1.17

One Year Ago EPS$42.83

Actual Revenue$25.87B

Expected Revenue$25.66B

Beat/MissBeat by +$207.70M

YoY Revenue Growth+10.81%

QuarterQ3 2026

Date04/30/2026

TimeAfter Close

Conference CallThursday, April 30, 2026

MX:RMD Upcoming Earnings

Resmed's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

MX:RMD Q3 2026 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2027 (Q1)	48.45 / -	46.087	―
Aug 06, 2026	2026 (Q4)	52.29 / 53.32	46.087	15.69% (+7.23)
Apr 30, 2026	2026 (Q3)	50.52 / 51.69	42.834	20.68% (+8.86)
Jan 29, 2026	2026 (Q2)	49.61 / 50.79	43.918	15.64% (+6.87)
Oct 30, 2025	2026 (Q1)	45.49 / 46.09	39.761	15.91% (+6.33)
Jul 31, 2025	2025 (Q4)	45.04 / 46.09	37.593	22.60% (+8.49)
Apr 23, 2025	2025 (Q3)	42.98 / 42.83	38.496	11.27% (+4.34)
Jan 30, 2025	2025 (Q2)	41.86 / 43.92	33.978	29.26% (+9.94)
Oct 24, 2024	2025 (Q1)	37.12 / 39.76	29.64	34.15% (+10.12)
Aug 01, 2024	2024 (Q4)	37.65 / 37.59	28.917	30.00% (+8.68)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed